The models confirmed a significant increase in tumor samples for both TIGIT (tumor vs. margin: β = 0.0803; SE = 0.0097; df = 130.00; p < 0.0001) and CD155 (tumor vs. margin: β = 0.1052; SE = 0.0101; df = 128.94; p < 0.0001). This evidence concerns the gene PVR and neoplasm.